Related Experiment Video
Updated: Jul 20, 2025

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
Published on: May 10, 2021
The association between CHA2DS2-VASc score and aortic valve sclerosis
Funda Başyiğit1, Havva Tuğba Gürsoy1, Özlem Özcan Çelebi1
1Department of Cardiology, Ankara City Hospital, Ankara, Turkey.
Insights
Aortic valve sclerosis (AVS) is linked to higher CHA2DS2-VASc scores, indicating increased cardiovascular risk. This finding suggests AVS may serve as a predictor for cardiovascular events in the general population.
Area of Science:
- Cardiology
- Valvular Heart Disease
- Thrombosis
Background:
- Antithrombotic therapy for atrial fibrillation commonly utilizes the CHA2DS2-VASc score.
- Aortic valve sclerosis (AVS) involves aortic valve thickening without motion restriction and is associated with cardiovascular risk factors.
Purpose of the Study:
- To investigate the association between the presence of aortic valve sclerosis (AVS) and the CHA2DS2-VASc score.
Main Methods:
- A cross-sectional, observational study included 411 patients with AVS (grades 1-3) and 102 patients without AVS (grade 0).
- CHA2DS2-VASc scores were compared between patients with and without AVS.
Main Results:
- The group with AVS exhibited significantly higher CHA2DS2-VASc scores compared to the group without AVS (median 3 vs. 1, p < 0.001).
Conclusions:
- Patients with aortic valve sclerosis have a higher CHA2DS2-VASc score.
- AVS may serve as a potential predictor of cardiovascular risk in the general population.
Background:
Antithrombotic therapy in atrial fibrillation is generally managed with the CHA2DS2-VASc score. Aortic valve sclerosis (AVS) is a focal thickening of the aortic valve without a restriction of motion. AVS is related to several cardiovascular risk factors. Our study was performed to evaluate whether the presence of AVS was associated with the CHA2DS2-VASc score.
Methods:
This cross-sectional, observational study comprised 411 patients with AVS grades 1-3 [AVS (+)] and 102 patients with AVS grade 0 [AVS (-)]. We compared CHA2DS2-VASc scores between the AVS (+) and AVS (-) groups.
Results:
We determined that the AVS (+) group had a higher CHA2DS2-VASc score than the AVS (-) group [3 (0-8) vs 1 (0-4), p < 0.001)].
Conclusions:
In our study, the CHA2DS2-VASc score was found to be higher in patients with AVS than in those without AVS. AVS may predict cardiovascular risk in the general population.
More Related Videos
06:57Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
04:48Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Mitral Stenosis I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation